[
  {
    "question": "What was the purpose of the study using Tacrolimus (Protopic) for seborrheic dermatitis?",
    "answer": "The purpose of the study was to evaluate the interest of Tacrolimus Ointment (PROTOPIC Â®) in the maintenance treatment of severe seborrheic dermatitis on the adult face. The aim was to assess its effectiveness and tolerability in reducing the frequency of relapses, prolonging remissions, and minimizing the use of topical steroids."
  },
  {
    "question": "Which countries were involved in the study evaluating Eliglustat for Gaucher Disease Type IIIB?",
    "answer": "The study evaluating Eliglustat (Cerdelga) for Gaucher Disease Type IIIB was conducted in Taiwan."
  },
  {
    "question": "What were the main inclusion criteria for the da Vinci SP robotic surgery study?",
    "answer": "Inclusion criteria included: documented informed consent, patients scheduled to undergo robot-assisted abdominal or pelvic procedures, and age over 18 years."
  },
  {
    "question": "What were the primary outcomes measured in the study on robotic surgery with the da Vinci SP system?",
    "answer": "The primary outcomes were: (1) conversion of operation to laparotomy, and (2) incidence of major surgical complications, assessed by Clavien-Dindo classification grade 3 or higher."
  },
  {
    "question": "What was the age range eligible for the multiple sclerosis study involving ublituximab?",
    "answer": "Participants eligible for the ublituximab study had to be between 18 and 65 years old."
  },
  {
    "question": "Which study investigated adverse events as a primary outcome for Gaucher disease?",
    "answer": "The study titled 'Eliglustat on Gaucher Disease Type IIIB' had adverse events as the primary outcome, measuring the number of adverse events in patients receiving the combination of Cerdelga and Cerezyme."
  },
  {
    "question": "Was there a study focusing on using stable calcium isotopes for diagnosing bone disorders?",
    "answer": "Yes, the 'Endogenous Calcium Stable Isotope Study (eCaSIS)' explored the diagnostic value of MC-ICP-MS measurement of stable calcium isotopes in plasma and urine for diagnosing bone and calcium disorders like osteoporosis and osteomalacia."
  },
  {
    "question": "What were the exclusion criteria for the seborrheic dermatitis study using Protopic?",
    "answer": "Exclusion criteria included prior treatment with Protopic for seborrheic dermatitis, lack of remission after initial treatment, and various medical conditions such as known immunodeficiency, recent UV therapy, or history of cancer or chronic pancreatitis."
  },
  {
    "question": "What interventions were tested in the clinical trial for Gaucher Disease Type IIIB started in 2018?",
    "answer": "The interventions included Eliglustat (Cerdelga) and Cerezyme, used in combination to assess safety and efficacy on soft tissue diseases."
  },
  {
    "question": "Which clinical trial investigated the use of robotic systems for less invasive abdominal surgeries?",
    "answer": "The trial titled 'The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical Procedures' evaluated the safety and effectiveness of the da Vinci SP1098 robotic system."
  }
]

